(Q43563793)

24 November 2017

title

Nitrofurantoin quadruple therapy for Helicobacter pylori infection: effect of metronidazole resistance (English)

1 reference

Helicobacter pylori infectious disease

24 November 2017

1 reference

1 reference

1 reference

1 reference

1

Graham DY

1 reference

24 November 2017

Saeed MA

2

1 reference

24 November 2017

Hoffman J

3

1 reference

24 November 2017

El-Zimaity HM

4

1 reference

24 November 2017

Kwon DH

5

1 reference

24 November 2017

Osato MS

6

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

Alimentary Pharmacology & Therapeutics

24 November 2017

published in

1 reference

24 November 2017

volume

15

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

513-518

1 reference

Rapid increase in the prevalence of metronidazole-resistant Helicobacter pylori in the Netherlands

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00945.X

Isolation and characterization of Campylobacter pyloridis from gastric biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00945.X

Nitrofurantoin: mechanism of action and implications for resistance development in common uropathogens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00945.X

Resistance to the nitroheterocyclic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00945.X

Furazolidone combination therapies for Helicobacter pylori infection in the United States.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00945.X

Evaluation of gastric mucosal biopsy site and number for identification of Helicobacter pylori or intestinal metaplasia: role of the Sydney System

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00945.X

Simultaneous visualization of Helicobacter pylori and gastric morphology: a new stain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00945.X

Quickbasic program for exact and mid-P confidence intervals for a binomial proportion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00945.X

Demonstration of unexpected antibiotic resistance of genotypically identical Helicobacter pylori isolates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00945.X

Analysis of rdxA and involvement of additional genes encoding NAD(P)H flavin oxidoreductase (FrxA) and ferredoxin-like protein (FdxB) in metronidazole resistance of Helicobacter pylori.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00945.X

Furazolidone- and nitrofurantoin-resistant Helicobacter pylori: prevalence and role of genes involved in metronidazole resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00945.X

Nitroimidazole drugs-action and resistance mechanisms I. Mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00945.X

The mechanism of action of nitro-heterocyclic antimicrobial drugs. Metabolic activation by micro-organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00945.X

Furazolidone versus metronidazole in quadruple therapy for eradication of Helicobacter pylori in duodenal ulcer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.2001.00945.X

10.1046/J.1365-2036.2001.00945.X

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference